Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Jeffrey Lisiecki

Plastic Surgery New York, NY Medical Doctor

NPI 1447630199 CMS profile 7233448

737 Park Ave Apt 1C, New York, NY 10021

Open in the dashboard

General payments

$5,931

69 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jeffrey Lisiecki of New York, NY is reported in the CMS Open Payments database as having received $5,931 across 69 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 74th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,410 17
2024 General $926 11
2023 General $594 12
2022 General $1,579 25
2021 General $306 3
2020 General $117 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jeffrey Lisiecki
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Jeffrey Lisiecki were reported at $2,410. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Jeffrey Lisiecki Plastic Surgery median Middle half National median
2019 $0 $371 $122–$1,483 $163
2020 $117 $158 $52–$438 $114
2021 $306 $249 $87–$752 $132
2022 $1,579 $274 $102–$793 $149
2023 $594 $299 $113–$891 $160
2024 $926 $361 $124–$1,062 $164
2025 $2,410 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. AbbVie, Inc. $2,804 29 payments
  2. Allergan Inc. $848 11 payments
  3. Musculoskeletal Transplant Foundation Inc. $404 2 payments
  4. Merz North America, Inc. $360 6 payments
  5. Sientra, Inc. $343 5 payments
  6. Davol Inc. $282 3 payments
  7. Motiva USA, LLC $242 2 payments
  8. Solta Medical, a division of Bausch Health US, LLC $198 1 payment
  9. Revance Therapeutics, Inc. $192 4 payments
  10. Bard Peripheral Vascular, Inc. $127 1 payment
  11. Other $131 5 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $4,750 66 payments
  2. Travel and Lodging $1,181 3 payments
Products named General payments · program years 2020–2025
  1. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $2,573 24 payments
  2. BOTOX $579 10 payments
  3. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $343 5 payments
  4. Motiva Implant Matrix $242 2 payments
  5. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $240 4 payments
  6. DAXXIFY $192 4 payments
  7. Agento I.C. Silver-Coated Endotracheal Tube $124 1 payment
  8. NATRELLE $117 1 payment
  9. Phasix Mesh $47 1 payment
  10. MENTOR MemoryGel Resterilizable Gel Sizer $40 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

69 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record